Skip to main content

NUVL

Nuvalent, Inc.

Company with tickers: NUVL

CIK
1861560
CUSIP
670703107
Shares Outstanding
73,692,987
Investor Relations
https://investors.nuvalent.com/
13F Activity (30d)
8 filings 4 filers

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-04-30 DEBORAH MILLER 16,500
2026-03-30 Darlene Noci 22,000
2026-03-24 Alexandra Balcom 59,420
2026-03-12 HENRY E PELISH 38,197
2026-03-06 James Richard Porter 90,000
2026-02-17 Matthew Shair 1,650
2026-02-17 Matthew Shair 5,850
2026-01-22 DEBORAH MILLER 21,000
2026-01-05 James Richard Porter 17,890
2026-01-05 Henry E. Pelish 2,496
2026-01-05 Deborah Ann Miller 4,363
2026-01-05 Alexandra Balcom 4,236
2026-01-05 Darlene Noci 4,236
2026-01-05 Christopher Durant Turner 4,236
2025-12-30 Darlene Noci 15,000
2025-12-08 Alexandra Balcom 7,084
2025-11-17 Alexandra Balcom 13,854
2025-11-17 DEBORAH MILLER 17,200
2025-10-30 DEBORAH MILLER 22,800
2025-10-27 Matthew Shair 18,150
2025-10-27 Matthew Shair 64,350
2025-10-16 James Richard Porter 27,000
2025-10-15 DEBORAH MILLER 54,000
2025-10-14 Alexandra Balcom 48,558
2025-10-14 HENRY E PELISH 21,842
2025-09-29 Alexandra Balcom 60,000
2025-09-29 Darlene Noci 12,000
2025-09-10 HENRY E PELISH 6,158
2025-07-24 Bain Capital Life Sciences Fund II, L.P. 1,286,344
2025-07-24 BCIP Life Sciences Associates, LP 156,670
2025-07-24 BCLS II INVESTCO, LP 4,253
2025-07-15 James Richard Porter 81,000
2025-07-09 Henry E. Pelish 2,145
2025-06-27 Alexandra Balcom 129,480
2025-06-26 Darlene Noci 12,000
2025-06-06 HENRY E PELISH 22,000
2025-04-15 James Richard Porter 81,000
2025-03-06 Darlene Noci 46,000
2025-01-15 James Richard Porter 81,000
2025-01-06 Henry E. Pelish 2,750
2025-01-06 Darlene Noci 4,250
2025-01-06 Alexandra Balcom 4,250
2025-01-06 Deborah Ann Miller 3,250
2025-01-06 James Richard Porter 18,000
2025-01-06 Christopher Durant Turner 4,250
2024-12-11 Bain Capital Life Sciences Fund II, L.P. 1,114,286
2024-12-11 BCIP Life Sciences Associates, LP 135,714
2024-11-25 Matthew Shair 8,000
2024-10-22 Deerfield Private Design Fund IV, L.P. 1,000,000
2024-10-22 Deerfield Healthcare Innovations Fund, L.P. 1,000,000
Showing 1–50 of 80 filings